The journal Expert Review of Vaccines just published a major, open-access review of the PfSPZ Vaccines co-authored by Sanaria’s staff and 21 collaborators from 25 institutions in the US, Europe, and Africa.  The 24,000 word manuscript describes the origins, development, current status and future of Sanaria’s various vaccine platforms, emphasizing the unparalleled safety and protective efficacy of PfSPZ vaccines, innovations that have propelled progress, the critical role played by our collaborators, and the promise of PfSPZ vaccines to reduce the burden of malaria in travelers and residents of malaria-endemic areas across the world.

In a publication in Science Translational Medicine, Sean Murphy, Stefan Kappe and colleagues at Seattle Children’s Research Institute (SCRI) report the safety and efficacy against controlled human malaria infection of the administration by mosquito bite of Plasmodium falciparum (Pf) parasites attenuated by deletion of three genes.